Autopsy report · NCT04189601
Complement Activation in the Lysosomal Storage Disorders
Cause of deathStaffing, sites or logistics
“Principal Investigator Dr. Thomas Barbour passed away.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Melbourne Health
- Sponsor type
- University, hospital or other
- Conditions
- Fabry Disease; Gaucher Disease; Niemann-Pick Disease, Type C; Lysosomal Storage Diseases
- Interventions
- Complement measurements
- Participants
- 0
- Sites
- 1
- Countries
- Australia
Trials that died the same way
- The Effects of Sound Energy on Pulmonary Gas Exchange
“Principal Investigator passed away.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.